Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss

@article{Shin2007EfficacyO5,
  title={Efficacy of 5\% Minoxidil versus Combined 5\% Minoxidil and 0.01\% Tretinoin for Male Pattern Hair Loss},
  author={Hyoseung Shin and Chong Hyun Won and Seung Ho Lee and Oh Sang Kwon and Kyu Han Kim and Hee Chul Eun},
  journal={American Journal of Clinical Dermatology},
  year={2007},
  volume={8},
  pages={285-290}
}
AbstractBackground: 5% topical minoxidil solution has been widely used to stimulate new hair growth and help stop hair loss in men with androgenetic alopecia (AGA). However, it is not convenient for patients to continue applying the solution twice daily on a regular basis. Tretinoin is known to increase the percutaneous absorption of minoxidil and, therefore, to enhance the response of AGA to minoxidil. For this reason, it was assumed that tretinoin would be helpful in alleviating the… 

Evaluation of safety of minoxidil 5% + chamomile 7% topical solution

Application of minoxidil 5% + chamomile 7% topical solution on human volunteers has not shown any adverse effects and these formulations could be recommended to use.

Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia

Topical Minoxidil 5% is equally effective to combination of topical MinoxIDil 5%, azelaic acid 1.5% and tretinoin 0.01% in treatment of androgenetic alopecia.

Comparison of efficacy of topical 5% minoxidil alone versus topical 5% minoxidil with autologous Platelet Rich Plasma (PRP) therapy in treatment of androgenetic alopecia: A randomised open label study

PRP treatment has a positive therapeutic effect on male Androgenetic alopecia without major side effects and highly significant increase in hair density was achieved after 4 months of treatment.

A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study

Topical minoxidil gel 5% and topical spironolactone gel 1% were effective in treatment of AGA, while the combination of two agents was better in treatment.

Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia, comparative study.

Both spironolactone as a 5% topical solution and minoxidil as a5% topical solutions might be used safely in a twice-daily dosage to treat AGA in both genders, combining them in a single topical dose form can boost efficacy and yield greater advantages.

Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata

  • M. Unal
  • Medicine
    Dermatologic therapy
  • 2018
Adapalene can be used as a new therapeutic modality in AA and is revealed the efficacy and safety of adapalenes and mometasone furoate combination in AA.

Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.

Mesotherapy, containing nutritional supplements only, is an effective, more acceptable to patients, and more tolerable modality compared with topical minoxidil in the treatment of FPHL.

Is Minoxidil Efficacious and Safe for the Treatment of Androgenetic Alopecia (AGA) in Men, and If So, What Is the Optimal Strength and Means of Delivery?

Minoxidil is safe and efficacious in the treatment of male AGA especially at the strength of 5% in either foam or solution preparation for twice daily use.

Topical valproic acid increases the hair count in male patients with androgenetic alopecia: A randomized, comparative, clinical feasibility study using phototrichogram analysis

Topical VPA increased the total hair counts of the authors' patients; therefore, it is a potential treatment option for androgenetic alopecia (AGA) and should be considered for further studies.

Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia

Overall developed liposome loaded hydrogel system showed potential for effective and simultaneous delivery of both the drugs.

References

SHOWING 1-10 OF 20 REFERENCES

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

Data from a patient questionnaire demonstrated that 5% topical minoxidil helped improve patients' psychosocial perceptions of hair loss in men with androgenetic alopecia as well as boosting hair regrowth in this 48-week trial.

Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution

Percutaneous minoxidil absorption is enhanced by tretinoin as a result of increased stratum corneum permeability, and transepidermal water loss measurements, which are sensitive to changes in stratum Corneum function, were significantly increased with t retinoin.

Topical tretinoin for hair growth promotion.

Action of topical minoxidil in the bald stump-tailed macaque.

The Effect of Topical Minoxidil on Hair Follicular Cycles of Rats

It is suggested that minoxidil specifically stimulates the secondary germ of the telogen follicles, resulting in rapid progression to anagen follicles.

Minoxidil: mechanisms of action on hair growth

The current state of knowledge on the mode of action of minoxidil on hair growth is reviewed, and lines of future research are indicated that may be relevant to hair growth.

The additive effects of minoxidil and retinol on human hair growth in vitro.

It is found that the significant hair shaft elongation demonstrated after minoxidil plus retinol treatment would depend on the dual kinetics associated with the activations of Erk- and Akt-dependent pathways and the prevention of apoptosis by increasing the Bcl-2/Bax ratio.

Periodicity in the growth and shedding of hair

Overall annual periodicity was demonstrated, manifested by a maximal proportion of telogen hairs at the end of summer and the beginning of autumn in men with or without alopecia.